Data / Form D filings / Enveric Biosciences, Inc.
Enveric Biosciences, Inc.: Form D filings
Enveric Biosciences, Inc., a biotechnology company in Cambridge, MA, filed 10 Form D notices with the SEC between 2018 and 2026. The latest, on May 4, 2026, reports $5 million sold of a $5 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, Cambridge, MA, 02142
- Phone
- (617) 444-8400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 890821
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | New notice | $5,000,002 | $5,000,002 | 4 | Apr 17, 2026 | sec.gov | |
| Feb 11, 2026 | New notice | $1,450,017 | $1,450,017 | 5 | Jan 28, 2026 | sec.gov | |
| Dec 23, 2025 | New notice | $106,598 | $106,598 | 15 | Dec 12, 2025 | sec.gov | |
| Oct 3, 2025 | New notice | Indefinite | $0 | 12 | Sep 18, 2025 | sec.gov | |
| Apr 19, 2023 | Amendment | $12,780,000 | $12,780,000 | 2 | Jul 22, 2022 | sec.gov | |
| Aug 5, 2022 | New notice | $8,617,500 | $8,617,500 | 2 | Jul 22, 2022 | sec.gov | |
| Feb 24, 2021 | New notice | $8,398,625 | $0 | $8,398,625 | 6 | Feb 9, 2021 | sec.gov |
| Jan 20, 2021 | New notice | $8,249,959 | $0 | $8,249,959 | 6 | Jan 12, 2021 | sec.gov |
| Aug 28, 2018 | Amendment | $6,600,000 | $6,600,000 | 4 | Jul 30, 2018 | sec.gov | |
| Aug 2, 2018 | New notice | $6,000,000 | $6,000,000 | 3 | Jul 30, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph E. Tucker | Executive Officer, Director | Chief Executive Officer and Director |
| Kevin M. Coveney | Executive Officer | Chief Financial Officer |
| Michael D. Webb | Director | |
| George W. Kegler | Director | |
| Michael Schabacker | Director | |
| Frank Pasqualone | Director | |
| Sheila DeWitt | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 4, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Enveric Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.